Protecting Human Health through Biotechnology Breakthroughs and Platforms
On November 15, 2020, soon after 4 months in huge-scale Period 3 medical screening, Moderna gained resounding evidence that its new course of medicines dependent on messenger RNA encased in lipid nanoparticles could be properly deployed as a hugely powerful vaccine to overcome the COVID-19 pandemic.
